{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:39:47Z","timestamp":1789468787595,"version":"build-2803163510"},"reference-count":46,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of venous thromboembolism in children continues to rise, with the most recent analysis from the Pediatric Hospital Information Systems database in the United States reporting a 200-fold increase in pediatric hospitalization-related venous thromboembolism diagnoses over the past 2 decades. In the past decade, several pediatric venous thromboembolism risk prediction models have been published, in some cases derived from multi-institutional data, and multicenter randomized clinical trials of thromboembolism prevention in specific pediatric subpopulations have been conducted. Yet, apart from children hospitalized for COVID-19, guidelines for thromboprophylaxis (TP) in children that address several distinct at-risk subpopulations and settings for venous thromboembolism are presently lacking. It is becoming increasingly apparent that approaches to pharmacological TP for hospitalized children should be risk-stratified regarding a priori risks of both venous thromboembolism and clinically relevant bleeding. In this manuscript, we present model cases of common inpatient clinical scenarios and review the evidence related to venous thromboembolism risk models and pharmacological TP clinical trials in children, describing a pragmatic approach to pharmacological TP for each scenario. We then conclude by describing our evidence-informed, subpopulation- and setting-specific approach to pharmacological TP for the clinical scenarios and reviewing critical knowledge gaps well-suited for future pediatric trials to inform TP in children.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024026327","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:10:06Z","timestamp":1738620606000},"page":"2439-2446","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["How I approach pharmacological thromboprophylaxis in children"],"prefix":"10.1182","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-4975","authenticated-orcid":false,"given":"Anthony A.","family":"Sochet","sequence":"first","affiliation":[{"name":"1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"2Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1651-3620","authenticated-orcid":false,"given":"Amy","family":"Kiskaddon","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"3Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"4Heart Institute, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"5Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"3Institute for Clinical and Translational Research, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"},{"name":"5Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"6Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"7Cancer and Blood Disorders Institute, Johns Hopkins All Children\u2019s Hospital, St. Petersburg, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2025052211212473100_bib1","doi-asserted-by":"crossref","first-page":"e2021054649","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children's hospitals","volume":"149","author":"O'Brien","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"2025052211212473100_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PCC.0000000000002826","article-title":"A new risk assessment model for hospital-acquired venous thromboembolism in critically ill children: a report from the Children's Hospital-Acquired Thrombosis Consortium","volume":"23","author":"Jaffray","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"2025052211212473100_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpeds.2013.10.025","article-title":"Hospital-associated venous thromboembolism in children: incidence and clinical characteristics","volume":"164","author":"Takemoto","year":"2014","journal-title":"J Pediatr"},{"issue":"3","key":"2025052211212473100_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.14697","article-title":"Comparative validation study of risk assessment models for pediatric hospital-acquired venous thromboembolism","volume":"18","author":"Mahajerin","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2025052211212473100_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2020.06.013","article-title":"Risk factors for pediatric cerebral sinovenous thrombosis: a case-control study with case validation","volume":"194","author":"Sellers","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"2025052211212473100_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.thromres.2015.04.036","article-title":"Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery","volume":"136","author":"Arlikar","year":"2015","journal-title":"Thromb Res"},{"issue":"4","key":"2025052211212473100_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jpeds.2014.05.053","article-title":"Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study","volume":"165","author":"Atchison","year":"2014","journal-title":"J Pediatr"},{"key":"2025052211212473100_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpeds.2017.01.026","article-title":"Epidemiology of bleeding in critically ill children","volume":"184","author":"White","year":"2017","journal-title":"J Pediatr"},{"issue":"6","key":"2025052211212473100_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1542\/hpeds.2021-006386","article-title":"Outcomes of prophylactic enoxaparin against venous thromboembolism in hospitalized children","volume":"12","author":"Bennett","year":"2022","journal-title":"Hosp Pediatr"},{"key":"2025052211212473100_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2020.09.028","article-title":"Bayesian analysis of the epidemiology of bleeding in critically ill children","volume":"63","author":"Greenway","year":"2021","journal-title":"J Crit Care"},{"issue":"5","key":"2025052211212473100_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/CCM.0000000000000147","article-title":"A multinational study of thromboprophylaxis practice in critically ill children","volume":"42","author":"Faustino","year":"2014","journal-title":"Crit Care Med"},{"issue":"9","key":"2025052211212473100_bib12","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1097\/PCC.0000000000001614","article-title":"Multicenter review of current practices associated with venous thromboembolism prophylaxis in pediatric patients after trauma","volume":"19","author":"Bigelow","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"2025052211212473100_bib13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3182186ec0","article-title":"Survey of pharmacologic thromboprophylaxis in critically ill children","volume":"39","author":"Faustino","year":"2011","journal-title":"Crit Care Med"},{"issue":"7","key":"2025052211212473100_bib14","doi-asserted-by":"crossref","first-page":"e12793","DOI":"10.1002\/rth2.12793","article-title":"Current practices in pediatric hospital-acquired thromboembolism: survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium","volume":"6","author":"Abrams","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"2025052211212473100_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2017.11.019","article-title":"A multi-institutional registry of pediatric hospital-acquired thrombosis cases: the Children's Hospital-Acquired Thrombosis (CHAT) project","volume":"161","author":"Jaffray","year":"2018","journal-title":"Thromb Res"},{"issue":"4","key":"2025052211212473100_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0041-1729170","article-title":"Venous thromboembolism among noncritically ill hospitalized children: key considerations for the pediatric hospital medicine specialist","volume":"48","author":"Morrison","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"2025052211212473100_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.thromres.2022.10.010","article-title":"Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: a report from the Children's Hospital Acquired Thrombosis (CHAT) Consortium","volume":"220","author":"Silvey","year":"2022","journal-title":"Thromb Res"},{"issue":"2","key":"2025052211212473100_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1017\/S1047951117001755","article-title":"Risk factors for hospital-associated venous thromboembolism in critically ill children following cardiothoracic surgery or therapeutic cardiac catheterisation","volume":"28","author":"Atchison","year":"2018","journal-title":"Cardiol Young"},{"issue":"6","key":"2025052211212473100_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0041-1722847","article-title":"Venous thromboembolism among critically ill children: a narrative review","volume":"47","author":"Sochet","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2025052211212473100_bib17","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/PCC.0000000000003383","article-title":"Hospital-acquired venous thromboembolism and invasive mechanical ventilation: a report from the Children's Hospital Acquired Thrombosis Consortium","volume":"25","author":"Sochet","year":"2024","journal-title":"Pediatr Crit Care Med"},{"issue":"14","key":"2025052211212473100_bib48","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/CIRCULATIONAHA.110.006304","article-title":"Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery","volume":"124","author":"Manlhiot","year":"2011","journal-title":"Circulation"},{"issue":"2-3","key":"2025052211212473100_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"issue":"4","key":"2025052211212473100_bib42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"2025052211212473100_bib37","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/CCM.0000000000004784","article-title":"Efficacy of early prophylaxis against catheter-associated thrombosis in critically ill children: a Bayesian phase 2b randomized clinical trial","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit Care Med"},{"issue":"22","key":"2025052211212473100_bib27","doi-asserted-by":"crossref","first-page":"e021765","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study [published correction appears in J Am Heart Assoc. 2021;10(24):e020766]","volume":"10","author":"McCrindle","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"2025052211212473100_bib28","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2025052211212473100_bib32","doi-asserted-by":"crossref","first-page":"e2022056726","DOI":"10.1542\/peds.2022-056726","article-title":"Enoxaparin thromboprophylaxis in children hospitalized for COVID-19: a phase 2 trial","volume":"150","author":"Sochet","year":"2022","journal-title":"Pediatrics"},{"issue":"24","key":"2025052211212473100_bib29","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","article-title":"Apixaban for prevention of thromboembolism in pediatric heart disease","volume":"82","author":"Payne","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2025052211212473100_bib51","doi-asserted-by":"crossref","first-page":"e028957","DOI":"10.1161\/JAHA.122.028957","article-title":"Dabigatran for treatment and secondary prevention of venous thromboembolism in pediatric congenital heart disease","volume":"13","author":"Albisetti","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2025052211212473100_bib43","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial [published correction appears in Lancet Haematol. 2024. 11(6):e399]","volume":"11","author":"O'Brien","year":"2024","journal-title":"Lancet Haematol"},{"issue":"11","key":"2025052211212473100_bib18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4187\/respcare.11698","article-title":"Invasive mechanical ventilation and risk of hospital-acquired venous thromboembolism","volume":"69","author":"Havlicek","year":"2024","journal-title":"Respir Care"},{"issue":"1","key":"2025052211212473100_bib20","doi-asserted-by":"crossref","first-page":"e000084","DOI":"10.1136\/wjps-2019-000084","article-title":"Venous thromboembolism in children undergoing surgery: incidence, risk factors and related adverse events","volume":"3","author":"Mets","year":"2020","journal-title":"World J Pediatr Surg"},{"issue":"4","key":"2025052211212473100_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpedsurg.2018.09.017","article-title":"Venous thromboembolism following inpatient pediatric surgery: analysis of 153,220 patients","volume":"54","author":"Sherrod","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"1","key":"2025052211212473100_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PCC.0000000000001387","article-title":"Strategies for prevention and management of bleeding following pediatric cardiac surgery on cardiopulmonary bypass: a scoping review","volume":"19","author":"Siemens","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"2025052211212473100_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.blre.2018.06.003","article-title":"Are low-molecular-weight heparins safe and effective in children? A systematic review","volume":"33","author":"Klaassen","year":"2019","journal-title":"Blood Rev"},{"issue":"7","key":"2025052211212473100_bib26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0031-1297173","article-title":"Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies","volume":"37","author":"Bidlingmaier","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2025052211212473100_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood.2020010218","article-title":"Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C","volume":"138","author":"Whitworth","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2025052211212473100_bib31","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/jth.15073","article-title":"Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness","volume":"18","author":"Goldenberg","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2025052211212473100_bib33","doi-asserted-by":"crossref","first-page":"113624","DOI":"10.1016\/j.jpeds.2023.113624","article-title":"Clinical impact of a standardized risk-stratified thromboprophylaxis protocol for multisystem inflammatory syndrome in children","volume":"262","author":"Rajput","year":"2023","journal-title":"J Pediatr"},{"issue":"9","key":"2025052211212473100_bib34","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jtha.2023.05.020","article-title":"Thrombotic complications in children with coronavirus disease 2019 and multisystem inflammatory syndrome of childhood","volume":"21","author":"Kumar","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2025052211212473100_bib35","doi-asserted-by":"crossref","first-page":"114328","DOI":"10.1016\/j.jpeds.2024.114328","article-title":"Trends in the diagnosis of pediatric venous thromboembolism and arterial ischemic stroke during the COVID-19 pandemic: an administrative database study","volume":"276","author":"Kumar","year":"2025","journal-title":"J Pediatr"},{"issue":"3","key":"2025052211212473100_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MOP.0000000000001130","article-title":"Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children","volume":"34","author":"Dain","year":"2022","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"2025052211212473100_bib39","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1097\/CCM.0000000000004848","article-title":"Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children: a post hoc analysis of a Bayesian phase 2b randomized clinical trial","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit Care Med"},{"issue":"3","key":"2025052211212473100_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"Clark","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025052211212473100_bib41","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/PCC.0000000000003601","article-title":"Mechanical thromboprophylaxis and hospital-acquired venous thromboembolism among critically ill adolescents: a U.S. pediatric health information systems registry study, 2016-2023","volume":"26","author":"Betensky","year":"2025","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"2025052211212473100_bib44","doi-asserted-by":"crossref","first-page":"e12810","DOI":"10.1002\/rth2.12810","article-title":"Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: a report from the Children's Hospital-Acquired Thrombosis Consortium","volume":"6","author":"Stephens","year":"2022","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/21\/2439\/2375373\/blood_bld-2024-026327-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/21\/2439\/2375373\/blood_bld-2024-026327-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:21:33Z","timestamp":1747927293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/21\/2439\/535389\/How-I-approach-pharmacological-thromboprophylaxis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":46,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,5,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024026327","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,22]]},"published":{"date-parts":[[2025,5,22]]}}}